Table 1.
Variable | N° or median (range) |
---|---|
Patients (total) | 1891 |
Sex | |
Male | 1197 |
Female | 694 |
Age (years) | 65 (20–92) |
Indications for EBUS-TBNA | |
Lung cancer staging | 728 |
Pathological diagnosis and mutational status in advanced stage lung cancer | 401 |
Lymphadenopathy in previous malignancy | 320 |
Diagnosis of pulmonary lesions | 290 |
Unknown origin lymphadenopathy | 152 |